Skip to main content
. 2010 Nov 18;32(3):318–326. doi: 10.1093/carcin/bgq245

Table V.

Interaction between Runx, MAPK1, eIF4E and other genes in candidate pathway

Gene SNP HRG Pathway gene SNP HRG Combined risk
OR (95% CI) Interaction P value
Colon cancer
RUNX1 rs2300395 CC BMPR1B rs17616243 CT/TT 1.33 (1.08, 1.64) 0.024
BMPR1A rs7088641 TT 1.25 (1.03, 1.52) 0.042
rs7279123 CT/TT TGFBR1 rs10733710 AA 1.77 (1.09, 2.89) 0.0359
rs2248720 AA Smad7 rs4464148 TC/CC 1.38 (1.12, 1.71) 0.019
RUNX2 rs10948238 TT TGFBR1 rs1571590 GG 3.37 (1.48, 7.71) 0.0272
Smad3 rs16950687 GG 1.82 (1.06, 3.13) 0.013
Smad7 rs12953717 TT 2.18 (1.47, 3.24) 0.0056
RUNX3 rs6672420 AA NFκB1 rs230510 TT 1.50 (1.12, 2.01) 0.0239
TGFB1 rs4803455 AA 1.82 (1.38, 2.42) 0.0476
MAPK1 rs8136867 GG BMP4 rs17563 TT 1.57 (1.13, 2.19) 0.023
rs2298432 CC NFkB1 rs13117745 CC/CT 3.58 (1.56, 8.19) 0.0061
TGFBR1 rs6478974 TT 1.39 (1.11, 1.74) 0.0168
Rectal cancer
RUNX1 rs1981392 CC BMPR1A rs7088641 CC 2.94 (1.11, 7.73) 0.0171
rs1474479 AA TGFB1 rs1800469 AA 2.76 (1.11, 6.82) 0.0373
rs11702779 GG/GA Smad3 rs12708492 CT/TT 2.75 (1.49, 5.08) 0.0108
rs8134380 TT rs16950687 GG 5.05 (1.67, 15.26) 0.0084
rs17293443 CC 15.17 (1.95, 117.96) 0.0086
RUNX2 rs2819863 GC/CC Smad4 rs10502913 AA 3.30 (1.02, 10.60) 0.0496
rs7750470 CC Smad3 rs7163381 AA 12.01 (1.51, 95.46) 0.0119
NFKB1 rs230510 AA 3.99 (1.67, 9.53) 0.0216
RUNX3 rs6672420 TT BMPR1B rs13134042 GA/AA 1.75 (1.26, 2.44) 0.046
rs2135756 GG NFKB1 rs4648110 AA 2.97 (1.04, 8.50) 0.0375

HRG, high-risk genotype group.